European Journal of Paediatric Neurology

Papers
(The TQCC of European Journal of Paediatric Neurology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial50
The utility of creatine kinase in status dystonicus and pre-status dystonicus49
Motor imagery ability of children with duchenne muscular dystrophy: Reliability and validity of kinesthetic and Visual Imagery Questionnaire-10, and its association with cognitive status38
‘Focal Seizures in Dystonic Cerebral Palsy (DCP): Rare or common or both?37
CSF IL-6 in pediatric neuroinflammation: Diagnosing disease or driving therapy?30
Analysis of the relation between cerebrospinal fluid antibody titers and clinical characteristics in pediatric patients with anti-N-methyl-D-aspartate receptor encephalitis29
Autoimmune encephalitis in Israeli children – A retrospective nationwide study28
Luteolin use in Integrated Stress Response: insight from a case of EIF2AK2-related dystonia28
Associations between muscle morphology and spasticity in children with spastic cerebral palsy25
Pediatric varicella zoster virus associated arterial ischemic stroke – A post-pandemic rise in incidence in Denmark24
A life course perspective on mental disorders and psychopharmacologic drug use among persons living with cerebral palsy23
Spinal cord stimulation (SCS) induced favorable neuromodulative outcome in the treatment of chronic neuropathic pain syndrome in children23
Treatment response in children with relapsing MOG-antibody associated disease21
Clinical and genetic characteristics of pediatric hereditary spastic paraplegia in the Eastern Levant20
Peroxisomal disorders - incidences in Sweden20
Disruptive lesions can cause developmental anomalies in the fetal brain: Mini-review19
Clinical presentation, MR imaging and outcome in children with myelin oligodendrocyte glycoprotein antibody-negative acute disseminated encephalomyelitis19
The unmet need of psychopharmacological intervention for neuropsychiatric and neurodevelopmental comorbidities in Duchenne muscular dystrophy: report of 5 workshops18
Is late diagnosis of Duchenne muscular dystrophy still a reality?17
Unmet health care needs over the first 2 years after pediatric traumatic brain injury17
Quality of life in young adolescents with epilepsy: A case control study17
“Fidgety-like movements” in extremely preterm infants - A new entity of spontaneous movements16
The development of checklists and reference charts for activities of daily living of normal developing children15
Acute seizures and the risk of post-stroke epilepsy in children with arterial ischemic stroke15
Climate change and neurological disorders in childhood: A scoping review14
Genetic causes of infection induced encephalitis14
Fatigue, depression, and health-related quality of life in pediatric-onset multiple sclerosis: A comparative study from a tertiary care center14
Assessing communication, beyond just words13
Respiratory function in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a 1.5-year natural history study13
Clinical features, quality of life, and fatigue in children with myotonic dystrophy type 113
CSF IL-6 in children with neuroinflammatory conditions13
Seizures in children and adolescents with high-grade glioma: a retrospective, monocentric analysis13
From childhood to adulthood: Long-term assessment of continuous intrathecal baclofen therapy in non-ambulant spastic cerebral palsy13
GLUT1DS focus on dysarthria12
Distal arthrogryposis with impaired proprioception and touch: description of 9 additional cases harbouring novel PIEZO2 variants and literature review12
Not all acute peripheral facial palsy in children recovers completely: A telediagnostic follow-up study12
Behavioral problems in infants and young children with spinal muscular atrophy and their siblings: A cross-sectional study12
Bilateral frontal periventricular nodular heterotopia: a distinctive cortical malformation12
Pediatric Neurotuberculosis: A cases series and review of the literature11
Genotype variability in early-onset Hereditary Spastic Paraplegia: a single-center study11
Cost-effective diagnosis for children with developmental and epileptic encephalopathy phenotype11
The association of serum vitamin D concentrations in paediatric migraine11
Letter to the Editor in response to Dr. Josef Finsterer et al. “Intense work-up is required for pediatric COVID-related acute necrotizing encephalopathy with RANBP2 variants”11
Experience of nusinersen treatment in advanced spinal muscular atrophy type 1: Characteristics of late responders with delayed treatment efficacy11
Tumefactive demyelinating lesions: navigating the many faces of mimicry11
Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes11
Gene therapy offers promise, but timing is crucial for SMA treatment11
Dystonia during hand activity in children with spastic unilateral cerebral palsy, an observational study10
Genotypic and phenotypic spectrum of congenital myasthenic syndrome: Insights from Southeastern Türkiye10
Plant-derived cannabinoids for treatment of spasticity in children and adolescents with severe cerebral palsy: Double-blind, placebo-controlled trial10
Ultra-rare ultra-care: Assessing the impact of caring for children with ultra rare diseases10
CSF-profile and hypocretin levels in children with narcolepsy type 1 and 210
Sphenoid dysplasia in patients with neurofibromatosis type 1: Clinical features and imaging findings including cerebrospinal fluid alterations10
Reopening the Silk Road for rare neurological diseases10
Insights from European Reference Network for rare neurological disorders study surveys on diagnosis, treatment, and management of NKX2-1-related disorders10
Epilepsy in pediatric patients with PTEN hamartoma tumor syndrome: First step in recommendations for clinical management10
Prognostic significance of ACTN3 genotype in Duchenne muscular dystrophy: Findings from an Argentine patient cohort9
Editorial Board9
Health-related quality of life in 153 children with neuromuscular disorders in Latin America: is it age, functional dependence or diagnosis?9
The promise of personalized medicine in pediatric epilepsy – The time has come9
It's easier to relearn gross motor skills than learn them for the first time after injury: Empirical evidence informing the age at injury debate9
Reevaluating isolated central apnea in early-term and term newborns: A neurological red flag for perinatal stroke8
Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management8
Clinical correlation between disease progression and central vein sign in pediatric onset multiple sclerosis: A binational study8
Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution8
Pathological gait in Rett syndrome: Quantitative evaluation using three-dimensional gait analysis8
Prognostic factor identification and model construction in pediatric influenza-associated encephalopathy: A retrospective case-control study8
Frequency of an intrathecal IgM synthesis and MRZ reaction in children with MS8
Intense work-up is required for pediatric COVID-related acute necrotizing encephalopathy with RANBP2 variants8
Similar disease progression in nonsense Duchenne muscular dystrophy boys as general natural history: Single Brazilian center 15 years registry view8
Genotype – phenotype correlation of Spinal Muscular Atrophy in the era of disease modifying therapies: A tertiary Indian experience8
Behavioral, neurodevelopmental profile, and epilepsy trajectory in two series of SLC6A1-NDD: A retrospective study with comprehensive assessment, and a participatory database study8
Fat embolism syndrome in Duchenne muscular dystrophy: Report on a novel case and systematic literature review8
Provoked seizures might lead to a significant diagnosis delay in CLN28
Reliability and validity of a newly developed PANDAS/PANS questionnaire8
Predicting respiratory failure and outcome in pediatric Guillain-Barré syndrome7
Climate change and pediatric neurology: A call to action7
Are atypical knee jerk responses prognostic for cerebral palsy in high-risk infants and children?7
Clinical and radiological findings of posterior reversible encephalopathy syndrome in children: About 16 children hospitalized in the pediatric department of a Tunisian tertiary care hospital7
Harmful metabolic acidosis in children treated by ketogenic diet during prolonged general anesthesia for epilepsy surgery: A single center experience7
Advances in genetics: The start of a new stage for management of focal cortical malformations7
Limb girdle muscular dystrophies: striving to bridge a diagnostic gap7
Is ketogenic diet a ‘precision medicine’? Recent developments and future challenges7
Ocrelizumab in pediatric patients with MS: Efficacy, tolerability, and safety7
Neuro-developmental outcomes in infants with vitamin B12-deficiency and neurologic features7
Deepening the understanding of mechanisms of antiepileptic effects of the ketogenic diet in children with AFG2A-related encephalopathy7
Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec7
Determinants of long-term health-related quality of life in paediatric traumatic brain injury7
Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)7
SCN1A-Related Epilepsy With Spike-Wave Activation in Sleep: A Retrospective Cohort and Literature Review7
Room to improve: The diagnostic journey of Spinal Muscular Atrophy7
Long-term monitoring of children with Pseudo Tumor Cerebri Syndrome by transbulbar sonography7
Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseases6
Dystonia following acquired brain injury (ABI) in childhood – Not as common as we might think?6
Artificial intelligence in pediatric stroke: An ally in screening?6
“Deconstructing” upper limb function in dyskinetic cerebral palsy6
Understanding North Star Ambulatory Assessment total scores and their implications for standards of care using observational data6
Approach to childhood tremors: Insights from a pediatric neurologist6
Monocentric retrospective clinical outcome in a group of 13 patients with opsoclonus myoclonus syndrome, proposal of diagnostic algorithm and review of the literature6
Time to reconsider the complex febrile seizure entity6
Myotonic dystrophy type 1 (Steinert disease): 29 years of experience at a tertiary pediatric hospital6
Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome6
Reduced elbow muscle strength in children and adolescents with Charcot-Marie-Tooth disease: a case control study6
Neurological and psychiatric phenotype of a multicenter cohort of patients with SETD5-related neurodevelopmental disorder6
Transition from paediatric to adult care in paediatric-onset neurological disorders in Europe: A survey and scoping review6
Identification of PMD subgroups using a myelination score for PMD6
Optimising patient care, expectations and experiences: Healthcare providers’ experiences of delivering sleep medicine services within an Australian tertiary paediatric facility6
Bradykinesia assessment in children with cerebral palsy and periventricular leukomalacia6
Transcranial magnetic stimulation in children with fetal alcohol spectrum disorder: A randomised, crossover pilot-trial5
Mitochondrial encephalopathies and myopathies: Our tertiary center's experience5
Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases5
Developmental and epileptic encephalopathy 56 due to YWHAG variants: 12 new cases and review of the literature5
Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial5
A novel approach to seizures in neonates5
Editorial Board5
Effects of motor imagery adding to physiotherapy and rehabilitation program in children with Duchenne Muscular Dystrophy: does it make a difference?5
Validation of the Observer-Reported Communication Ability (ORCA) measure for individuals with Rett syndrome5
Outcome of herpes simplex virus encephalitis in children and young people5
Complex febrile seizures: urgent need to reconsider existing guidelines – how soon is now?5
In search of “what really matters”: Insights from a web-based survey on Patient-Centered Outcomes in GLUT1DS5
Phenotypic expansion of EGP5-related Vici syndrome: 15 Dutch patients carrying a founder variant5
Impact of lesion metrics and neurological functions on long-term cognitive outcome in childhood stroke5
Unravelling key pathways in childhood ataxia to guide diagnosis and treatment5
CLN2 disease: why early diagnosis matters more than ever5
Real life retrospective study of cannabidiol therapy in alternating hemiplegia of childhood5
Efficacy and safety of Nusinersen among children with spinal muscular atrophy from North India: A prospective cohort study (NICE-SMA study)5
Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials5
Brain morphometry and psychomotor development in children with PCH2A5
Reassuring neuropsychological outcome data in myelin oligodendrocyte glycoprotein antibody-associated disease5
Pediatric-onset multiple sclerosis in Greece: A single-center study of the risk factors and a review of the literature5
Lesion size and long-term cognitive outcome after pediatric stroke: A comparison between two techniques to assess lesion size5
Treatments of paediatric multiple sclerosis: Efficacy and tolerance in a longitudinal follow-up study5
Corrigendum to “Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC” [J. Eur. Paediatr. Neurol. 20 (2) (2016) 203–211]5
Paradoxical Reactions in Pediatric HIV-negative CNS Tuberculosis: A longitudinal cohort study5
Education and participation in children and adolescents with Duchenne muscular dystrophy in Switzerland5
0.32539796829224